finding that substantiated the ability of a natural compound of local plant origin to eliminate cancer cells of the cervix.

It has safer anti-cancer properties as it specifically targets cancer cells and does not cause damage to normal cell tissues even at high dosages, unlike most synthetic anti-cancer drugs which are highly toxic, local media reports

said today.

BioMedical Sciences Department lecturer and research associate Dr Ahmad Bustamam Abdul, who led the team, said, own that this natural compound is able to inhibit the progression of cervical intraepithelial neoplasia (CIN) stage III in animal disease model studies."

The compound had similar efficacy to commercial anti-cancer drugs used frequently to treat cervical cancer but delivering lesser toxicity in normal human cells, he said.

"Our data also showed that laboratory rats could withstand high dosages of the compound without any damage to normal tissues," he said. The compound, which can be commercialised in the form of feminine douches and suppositories, does not have any known side effects, he said.

He said the commercialisation of the technology would definitely reduce the cost of importing therapeutic drugs and treating cervical cancer patients as the compound could be used as an adjuvant to current chemotherapy.

A patent has been filed in respect of the technology in the use of plant metabolite as an anti-cancer alternative. Cervical cancer is abnormal cell growth in the cervix which is primarily caused by the Human Papillomavirus (HPV).